Community Search
WPC Scientific Update 2015
Share |

 

 

>Register HERE!

>General Information

>Program

>Faculty

>Continuing Education




 


Program

Download summaries of all SIX sessions
 


Presented on October 6, 2015


SESSION I- New Therapeutic Strategies for Parkinson's

 

Learning Objectives: To discuss new innovations in therapy from three angles, including pharmacological, reparative strategies such as DBS, and mechanical bio-engineering; To understand the potential roles and limitations of existing and emerging non-pharmacological approaches to the management of Parkinson's as well as other potential applications.

Moderator:
A. Jon Stoessl (Canada)
Speakers:
 

New ways to think about pharmacology for Parkinson's

Peter LeWitt (USA)

DBS: New understanding and uses  

Andres Lozano (Canada)

Bioengineering instruments and Parkinson's: a new management tool?  

Sunil Agrawal (USA)

Download Session I Summary
  

 

SESSION II- Alpha-nuclein why is it so important to Parkinson's?

  

Learning Objectives: To understand the importance of the mechanisms responsible for the maintenance of the well being of proteins.


Moderator:
Andrew Singleton (USA)
Speakers:  

GBA

Roy Alcalay (USA)

LRRK2 as a kinase

Andrew West (USA)

Alpha synuclein, example of aggregation prone factors

Tiago Outeiro (Germany)

Download Session II Summary
 



 


 

Presented on October 7, 2015

 

SESSION III- Emerging Targets in Parkinson's

 

Learning Objectives: To understand current unmet needs and appreciate the obstacles that must be overcome in order to develop a neuroprotective therapy; To understand how to identify targets to alleviate the symptoms unresponsive to dopaminergic treatment or the side effects of dopaminergic treatments.

Moderator:
Etienne Hirsch (France)
Speakers:

New targets covering side effects of PD treatments

Erwan Bezard (France)  

Ongoing pursuit of neuroprotective therapies

Tom Foltynie (UK)

Non-motor issues: different ways to think about targets

K. Ray Chaudhuri (UK)


 
Download Session III Summary
 


 

SESSION IV- Exercise: What do we know about how it impacts Parkinson's?

 

Learning Objectives: To explain how exercise impacts a Parkinson patient's health and well being from three perspectives, including neurophysiological impact, clinical impact, and rehabilitation impact.

Moderator:
Fay Horak (USA)
Speakers:
 

What happens in the brain when exercise happens?

Richard Smeyne (USA)

Clinical dimension of exercise and PD

Giselle Petzinger (USA)

Where does exercise meet rehabilitation & why?

Gammon Earhart (USA)

 
Download Session IV Summary
 




 


Presented on October 8, 2015

 

SESSION V- Cognitive Challenges and Parkinson's: What can really be done?

 

Learning Objectives: To describe the clinical features, syndromes and proposed mechanisms of cognitive dysfunction across the spectrum of Parkinson's disease; To describe the available and emerging treatments for cognitive impairment associated with Parkinson's.

Moderator:
David Burn (UK)
Speakers:
 

Cognition across the life span: the cause and progression

Dag Aarsland (Sweden)

Mild cognitive impairment in Parkinson's- what does it mean?

Alexander Troster (USA)

Emerging therapies for cognition: what can we expect?

Jennifer Goldman (USA)

Download Session V Summary
 

 

SESSION VI- Gene & Stem Cell Therapy: Can these really impact Parkinson's?

 

Learning Objectives: To appreciate the experimental development and current applications of cell and gene based therapies.

Moderator:
Jeffrey Kordower (USA)
Speakers:
 

Viral vectors & overview of cellular implanting

Krystof Bankiewicz (USA)

Antisense oligonucleotide: a form of non-viral based therapy

Marie-Francoise Chesselet (USA)

Stem cells

Roger Barker (UK)


Download Session VI Summary
 




Register NOW!




Membership Management Software Powered by YourMembership  ::  Legal